Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aiju Biotechnology appears to be a China-based agricultural biotechnology and agrochemical company rather than a human healthcare or therapeutics developer. The company is registered as Aiju Biotechnology (Shandong) Co., Ltd. and is engaged in biopesticide technology R&D, bio-organic fertilizer R&D, biomaterial-related activities, feed additives, and pesticide, fertilizer, and feed production and sales. Public business registry descriptions indicate it operates commercially in crop protection and agricultural inputs, with manufacturing and trading activity rather than a disclosed clinical-stage drug pipeline. Based on the available evidence, it should not be classified as a life science therapeutics, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aiju Biotechnology.